India's Bharat Biotech said on Wednesday it followed a "step-by-step" approach for the regulatory approval and supply contract of its COVID-19 vaccine in Brazil, and that it has not received advance payments from the Brazilian health ministry.
Brazil's health minister said on Tuesday the country will suspend its $324 million contract for 20 million doses of Bharat Biotech's vaccine after whistleblowers went public with alleged irregularities in the deal.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.